Financhill
Back

Palisade Bio, Inc. Vs. Madrigal Pharmaceuticals, Inc. Industry Stock Comparison

Sell
36

PALI
Palisade Bio, Inc.

Last Price:
$1.84
Seasonality Move:
-1.59%
Buy
67

MDGL
Madrigal Pharmaceuticals, Inc.

Last Price:
$591.74
Seasonality Move:
15.11%
Sell
36
Palisade Bio, Inc. (PALI) is a Sell

Is Palisade Bio, Inc. a Buy, Sell or Hold?

  • The current Palisade Bio, Inc. [PALI] share price is $1.83. The Score for PALI is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • PALI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Madrigal Pharmaceuticals, Inc. (MDGL) is a Buy

Is Madrigal Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $591.02. The Score for MDGL is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PALI Stock Price Chart

What is Palisade Bio, Inc.'s stock price today?

  • The Palisade Bio, Inc. share price today is $1.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PALI is experiencing buying pressure, which is a positive indicator for future bullish movement.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals, Inc.'s stock price today?

  • The Madrigal Pharmaceuticals, Inc. share price today is $591.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.

PALI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 48.4 Sell
Chaikin Money Flow: 6352780 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.77 - 2.17) Sell
Bollinger Bands (100): (0.8 - 1.98) Buy

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 12.54 Buy
Relative Strength Index (14 RSI): 63.09 Buy
Chaikin Money Flow: 850060 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (548.18 - 585.88) Buy
Bollinger Bands (100): (384.94 - 533.12) Buy

PALI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.87 Sell
20-day SMA: 1.93 Sell
50-day SMA: 1.9 Sell
200-day SMA: 1.08 Buy
8-day EMA: 0.92 Buy
20-day EMA: 0.45 Buy
50-day EMA: 0.2 Buy
200-day EMA: 0.05 Buy

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 561.5 Buy
20-day SMA: 571.82 Buy
50-day SMA: 508.82 Buy
200-day SMA: 382.95 Buy
8-day EMA: 564.29 Buy
20-day EMA: 558.29 Buy
50-day EMA: 520.52 Buy
200-day EMA: 411.49 Buy

Palisade Bio, Inc. Earnings Growth & PALI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.02 per share, and an increase next year of $0.45 per share.

Madrigal Pharmaceuticals, Inc. Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.33 per share, and an increase next year of $13.64 per share.

Palisade Bio, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Madrigal Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):